Evidence map›Paper›PMID 41383515›Full record

ReviewFrontiers in oncology2025

Advancements in real-time oncology diagnosis: harnessing AI and image fusion techniques.

Leila Bagheriye, Johan Kwisthout

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leila BagheriyeDonders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, Netherlands.
Johan KwisthoutDonders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Real-time computer-aided diagnosis using artificial intelligence (AI), with images, can help oncologists diagnose cancer with high accuracy and in an early phase. It explores various real-time techniques, encompassing technical solutions, AI-based imaging, and image fusion diagnosis. Techniques such as computer-aided surgical navigation systems and augmented reality platforms have improved the precision of minimally invasive procedures once combined with real-time imaging and robotic assistance. The integration of modalities like ultrasound into image fusion workflows improves procedural guidance, reduces radiation exposure, and provides high cross-modality interpretation. Optical imaging techniques-such as diffuse reflectance spectroscopy, Raman spectroscopy, fluorescence endoscopy, and hyperspectral imaging-are emerging as powerful diagnostic tools for tumor detection, margin assessment, and intraoperative decision-making. Promising methods like fluorescence confocal microscopy and shear wave elastography offer practical, real-time diagnostic capabilities. However, regarding these technologies, there are technical challenges including tissue motion, registration variability, and data imbalance. The incorporation of AI-based landmark detection and the development of robust algorithms will be key to overcoming these barriers. We close by offering a more futuristic overview to solve existing problems in real-time image-based cancer diagnosis. The reviewed technologies altogether mark that continued research, multi-center validation, and providing hardware accelerators will be crucial to their full clinical potential and usage.

Indexed as

artificial intelligencecancerdiagnosishardware acceleratorhyperspectral imagingimage fusionreal-timespectroscopy

Identifiers

PMID41383515
PMCPMC12689336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.